Regional Account Manager-Neurology (Michigan based Candidates)
Axsome Therapeutics IncSalary not specified
- Full Time
- Junior (1 to 2 years)
Cytokinetics
Cardiovascular Account Specialist - U.S. Sales, Grand Rapids, MI
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries
Requirements
Candidates must possess a Bachelor's degree and a minimum of 5 years of experience in biotech or pharmaceutical sales, with a strong preference for territory ownership experience. Prior experience in cardiology, rare diseases, or specialty products is desired, as is experience with specialty product launches.
Responsibilities
As a Cardiovascular Account Specialist, you will introduce Cytokinetics in your territory and launch its first commercial product, a cardiac myosin inhibitor for Hypertrophic Cardiomyopathy (HCM). You will be responsible for driving sales results, developing territory-specific account plans, identifying and developing strategic IDNs and Hospitals, and serving as a subject matter expert and resource for customers, delivering clinically relevant information and coordinating with a local integrated field team.
Skills
Biotech Sales
Pharmaceutical Sales
Territory Management
Account Planning
Stakeholder Collaboration
Clinical Knowledge
Cardiology
Rare Disease
Specialty Product Launch
Demand Generation
Patient Support
Cytokinetics
Develops drugs for muscle function disorders
About Cytokinetics
Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.
Key Metrics
South San Francisco, CaliforniaHeadquarters
1998Year Founded
$58.4MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees